Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     
Products, Tech

Zeiss reveals new diagnostic tech

31/10/2018By Matthew Woodley
Medical tech company Zeiss has unveiled its latest digital diagnostic technology for retinal diseases and glaucoma.

Making its debut at the combined European Society of Cataract and Refractive Surgeons (ESCRS) and European Society of Retina Specialists (EURETINA) exhibition in Vienna in September, Zeiss showcased what it described as “the next leap in multi-modality care”.

Its new Integrated Diagnostic Imaging platform integrates and transforms data from diagnostic devices by combining modalities. It develops simple individualised assessments, aimed at helping doctors efficiently make best treatment decisions.

According to retina and vitreous surgeon Dr Peter Karth, such integration is crucial for effectively detecting, diagnosing and treating retinal disease.

“One of the biggest challenges in retina practices today is viewing and integrating multimodal imaging to efficiently and fully assess macular disease in busy clinics,” he said.

“I consider the Zeiss Integrated Diagnostic Imaging platform to be a key part of patient management, giving me the data integration that I need to make the best decisions for my patients.”

Zeiss also revealed its latest innovation for astigmatism management: the new IOL Master 700 with Total Keratometry (TK). This allows cataract surgeons to replace assumptions with precise measurements of the posterior corneal surface.

Meanwhile, Zeiss’ global president of ophthalmic devices Mr Jim Mazzo, also recently announced an important milestone for its laser eye surgery, SMILE (small incision lenticule extraction).

The minimally invasive procedure has been performed by 1,300 surgeons worldwide to treat ametropia in more than 1.5 million patients.

It involves using its VisuMax laser to create a thin, lenticular disc (lenticule) in the cornea, which is extracted by the surgeon through a small incision in the corneal surface. According to Zeiss, the virtually intact corneal surface minimises disruption to the biomechanics of the cornea.

Eyecare Plus

Editor's Suggestion
Hot Stories



Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!